Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 12.12% higher on its value in year-to-date trading and has touched a low of $13.12 and a high of $24.64 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $23.09 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $23.40, the stock is 3.46% and 6.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing 1.34% at the moment leaves the stock 21.87% off its SMA200. CPRX registered 71.81% gain for a year compared to 6-month gain of 51.07%. The firm has a 50-day simple moving average (SMA 50) of $21.9612 and a 200-day simple moving average (SMA200) of $19.1609.
The stock witnessed a 9.81% loss in the last 1 month and extending the period to 3 months gives it a 6.90%, and is -2.34% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.94% over the week and 5.52% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 167 employees, a market worth around $2.79B and $460.48M in sales. Current P/E ratio is 19.96 and Fwd P/E is 16.23. Profit margin for the company is 31.01%. Distance from 52-week low is 78.41% and -5.03% from its 52-week high. The company has generated returns on investments over the last 12 months (21.51%).
The EPS is expected to grow by 92.97% this year
446.0 institutions hold shares in Catalyst Pharmaceuticals Inc (CPRX), with institutional investors hold 89.17% of the company’s shares. The shares outstanding are 119.27M, and float is at 105.41M with Short Float at 6.29%. Institutions hold 83.50% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.69 million shares valued at $289.58 million. The investor’s holdings represent 16.0051 of the CPRX Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 9.13 million shares valued at $141.38 million to account for 7.8141 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 8.1 million shares representing 6.9349 and valued at over $125.47 million, while STATE STREET CORP holds 5.1652 of the shares totaling 6.03 million with a market value of $93.46 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by Miller Steve, the company’s Chief Op. & Scientific Officer. SEC filings show that Miller Steve sold 50,000 shares of the company’s common stock on Dec 10 ’24 at a price of $21.93 per share for a total of $1.1 million. Following the sale, the insider now owns 0.69 million shares.
Still, SEC filings show that on Nov 27 ’24, INGENITO GARY (Chief Med. & Reg. Officer) disposed off 12,000 shares at an average price of $22.72 for $0.27 million. The insider now directly holds 51,391 shares of Catalyst Pharmaceuticals Inc (CPRX).
